Business
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
Eleven clinical studies presented at RSNA 2024 highlighted the growing clinician experience with the Swoop® system for imaging diverse patient groups in
About this update from Hyperfine, Inc.
[{"type":"text","content":"\nEleven clinical studies presented at RSNA 2024 highlighted the growing clinician experience with the Swoop® system for imaging diverse patient groups in emergency departments and neuro ICUs.\n\n\n GUILFORD, Conn.--(BUSINESS WIRE)--\nHyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today highlighted data and conclusions presented at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago. Contributions from eleven leading institutions—early adopters of point-of-care MR brain imaging technology—underscore the increasing utility of AI-powered portable MR imaging and the growing physician experience with its application, particularly for acute stroke diagnosis.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205620649/en/The Swoop® Portable MR Imaging® System (Photo: Business Wire)\nThe clinical studies presented clinician experience using Swoop® system images for intracerebral hemorrhage monitoring, acute ischemic stroke detection, and advanced imaging techniques for multiple sclerosis. These studies highlighted the potential of the Swoop® system to expand access to critical diagnostic imaging for acute ischemic stroke and other neurological conditions, providing actionable insights where conventional high-field MRI may not be viable.\n\n\nA team from Washington University School of Medicine in St. Louis, a leading center in AI-powered portable MR imaging utilization, showcased their experience with a presentation that marks the most extensive study to date using the Swoop® system, including data from over 350 exams in acute neurological care settings. In an abstract titled Application of clinical low field mobile MRI in a large academic medical center, neuroradiologists evaluated how Swoop® system images compare to conventional MRI (1.5T or 3T) in helping physicians identify brain pathologies. The study concludes that point-of-care low-field portable MR carries promise for rapid delivery of actionable diagnostic imaging to persons with acute neurological injury and should be considered for patients with acute stroke who cannot readily undergo conventional MRI.\n\n\nOne of...